Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prime Medicine, Inc.

3.74
-0.1800-4.59%
Pre-market: 3.860.1200+3.21%06:31 EDT
Volume:8.63M
Turnover:32.14M
Market Cap:490.03M
PE:-2.32
High:3.91
Open:3.62
Low:3.52
Close:3.92
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Biogen, Carvana, Cigna

Reuters
·
Yesterday

Prime Medicine Prices $125.4 Million Common Stock Offering; Shares Down Pre-Bell

MT Newswires Live
·
Yesterday

BRIEF-Prime Medicine Prices Public Offering At $3.30 Per Share

Reuters
·
Yesterday

Prime Medicine Announces Pricing of Public Offering

THOMSON REUTERS
·
Yesterday

Prime Medicine Inc. Announces Public Offering of Common Stock

Reuters
·
Yesterday

Prime Medicine Inc - Grants Underwriters Option for Additional 15% Shares

THOMSON REUTERS
·
Yesterday

Prime Medicine, Inc.: Buy Rating Affirmed on Innovative Gene Editing Technology and Strategic Advancements

TIPRANKS
·
17 Jul

Prime Medicine Secures Up to $24 Million from CF Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Reuters
·
16 Jul

Prime Medicine Inc. Announces Departure of Chief Scientific Officer Jeremy Duffield, Plans for Advisory Role

Reuters
·
16 Jul

JonesResearch lists factors for Prime Medicine continued share rally

TIPRANKS
·
08 Jul

Prime Medicine, Inc.: Buy Rating Driven by Strategic Positioning and Market Momentum

TIPRANKS
·
07 Jul

David R. Liu, 10% Owner, Reports Acquisition of Common Shares in Prime Medicine Inc

Reuters
·
02 Jul

David R. Liu, 10% Owner, Acquires Common Shares of Prime Medicine Inc

Reuters
·
24 Jun

David R. Liu, 10% Owner, Reports Acquisition of Common Shares in Prime Medicine Inc

Reuters
·
17 Jun

David R. Liu, 10% Owner, Reports Acquisition of Common Shares of Prime Medicine Inc

Reuters
·
13 Jun

Prime Medicine Inc. Conducted Annual Stockholders Meeting Virtually

Reuters
·
06 Jun

Prime Medicine Cut to Neutral From Buy by Citigroup

Dow Jones
·
27 May

Prime Medicine downgraded to Neutral from Buy at Citi

TIPRANKS
·
27 May

Hold Rating for Prime Medicine, Inc. Amid Financial Uncertainties and Strategic Adjustments

TIPRANKS
·
27 May

CEO Allan Reine Reports Acquisition of Common Shares of Prime Medicine Inc

Reuters
·
23 May